SCHEMBL16060484

SCHEMBL16060484

CCOC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1cccc(NS(=O)(=O)O)c1)c1nc(CC)cs1

nearest known ligand 0.87

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680101 0.93 PTPRB (1.00) PTPRB
SCHEMBL680102 0.93 PTPRB (1.00) PTPRB
SCHEMBL16061190 0.88 PTPRB (0.87) PTPRB
SCHEMBL16060468 0.87 PTPRB (0.69) PTPRB
SCHEMBL1287170 0.87 PTPRB (0.86) PTPRB
SCHEMBL468317 0.86 PTPRB (1.00) PTPRB
SCHEMBL680192 0.86 PTPRB (1.00) PTPRB
SCHEMBL16059578 0.85 PTPRB (0.86) PTPRB
Ammonia Solution, Strong SCHEMBL16030961 0.85 PTPRB (0.98) PTPRB
SCHEMBL16060955 0.85 PTPRB (0.87) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2967066-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics Inc. (US) 2016-01-20 EP disclosed
WO-2014145068-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES AERPIO THERAPEUTICS INC. (US) 2014-09-18 WO disclosed